| Literature DB >> 28387368 |
Liang Liu1, Junwei Gao1, Xie He1, Yulong Cai1, Lian Wang1, Xiaotang Fan1.
Abstract
The association between the use of assisted reproductive technology (ART) and autism spectrum disorder (ASD) risk in offspring has been explored in several studies, but the result is still inconclusive. We assessed the risk of ASD in offspring in relation to ART by conducting a meta-analysis. A literature search in PubMed, Embase, and Web of Knowledge databases through April 30, 2016 was conducted to identify all the relevant records. Risk ratios (RRs) and 95% confidence intervals (95%CIs) were computed to analyze the strength of association by using fixed- or random-effect models based on heterogeneity test in total and subgroup analyses. Analysis of the total 11 records (3 cohort studies and 8 case-control studies) revealed that the use of ART is associated with higher percentage of ASD (RR = 1.35, 95% CI: 1.09-1.68, P = 0.007). In addition, subgroup analyses based on study design, study location and study quality were conducted, and some subgroups also showed a statistically significant association. Our study indicated that the use of ART may associated with higher risk of ASD in the offspring. However, further prospective, large, and high-quality studies are still required.Entities:
Mesh:
Year: 2017 PMID: 28387368 PMCID: PMC5384197 DOI: 10.1038/srep46207
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of study identification.
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097. For more information, visit http://www.prisma-statement.org.
Characteristics of the studies included in the meta-analysis.
| Author (year) | Country | Diagnosis | Study design | Source of the study population | Study period | ART type | Outcome | case/control | RR(95%CI) | Adjusted factors | methodological quality |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Svahn | Denmark | ICD-8/ICD-10 | cohort | The computerized Civil Registration System | 1969– | NA | ASD | 2058/2410663 | 1.06(0.99, 1.14) | year of birth, birth order, sex, maternal age at birth, paternal age at birth and parental history of mental disorder | 8 |
| Kamowski-Shakibai | USA | NA | case-control | Children in the New York tri-state area | NA | ART | ASD | 8/155 | 1.73(0.33, 9.08) | NA | 2 |
| Fountain | USA | DSM-IV/code 299.0 | cohort | The California Birth Master Files for 1997–2007, the California DDS autism caseload records for 1997–2011, and the Centers for Disease Control and Prevention’s National ART Surveillance System for live births for 1997–2007 | 1997–2007 | ART | ASD | 31243/5529810 | 1.71(1.55, 1.89) | year of birth, infant’s gender, and mother’s education and race | 6 |
| Sandin | Sweden | ICD-9/ICD-10 | cohort | Swedish national registers | 1982–2009 | IVF with ICSI or without ICSI | autistic disorder | 6959/2541125 | 1.22(1.01, 1.49) | sex, attained age and birth year | 9 |
| Özbaran | Turkey | DSM-IV/ADSI/WISC-R | case-control | The outpatient clinic of Child and Adolescent Psychiatry Department of EUSM | NA | ART | Autism | 3/67 | 0.49(0.04, 5.61) | NA | 3 |
| Lehti | Finland | ICD-9/ICD-10 | case-control | The Finnish Hospital Discharge Register | 1991–2007 | IVF | ASD | 4164/16582 | 0.9(0.70, 1.30) | maternal age and SES, gestational age and parity | 8 |
| Grether | USA | ICD-9 | case-control | A KPNC facility | 1995–2002 | NA | ASD | 349/1847 | 0.99(0.67, 1.50) | maternal and paternal age, maternal race, maternal education, baby sex, gestational age, birth year, and birth facility | 6 |
| Lyall | USA | ADI-R | case-control | Participants in the Nurses’ Health Study II | 1989– | ART | ASD | 507/2529 | 1.11(0.77, 1.62) | maternal and paternal age, race, income, and birth order | 6 |
| Shimada | Japan | DSM-IV-TR | case-control | University of Tokyo Hospital/General Population of Tokyo | 2006–2009 | IVF; ICSI | ASD | 467/100118 | 1.84(1.18, 2.85) | NA | 2 |
| Zachor | Israel | DSM-IV-TR | case-control | Large Israel population from infant registry of Rabin Medical Center | 1995–2002 | IVF and ICSI | ASD | 285/53080 | 2.78(1.81, 4.27) | NA | 2 |
| Stein | Israel | ICD 8/DSM III/IV | case-control | ALUT center of Tel Aviv | 1970–1998 | Infertility requiring medical intervention | autism | 206/152 | 1.91(0.94, 3.88) | NA | 5 |
NA: no avalible; DDS: Department of Developmental Services; EUSM: Ege University School of Medicine.
Figure 2Forest plot of ASDs risk associated with ART using. ASDs, autism spectrum disorders; CI, confidence interval.
Summary of meta-analysis results.
| Groups | Studies | Test of association | Heterogeneity | |||||
|---|---|---|---|---|---|---|---|---|
| RR[95%CI] | p value | Model | Z | Χ2 | p value | |||
| Total studies | 11 | 1.35[1.09–1.68] | 0.007 | RE | 2.7 | 83.76 | 0 | 88.1 |
| Subgroup analyses | ||||||||
| study design | ||||||||
| cohort | 3 | 1.30[0.93–1.83] | 0.127 | RE | 1.52 | 59.36 | 0 | 96.6 |
| case-control | 8 | 1.40[0.99–1.98] | 0.06 | RE | 1.89 | 24.15 | 0.001 | 71 |
| scores | ||||||||
| high | 3 | 1.07[1.00–1.14] | 0.044 | FE | 2.02 | 3.02 | 0.221 | 33.7 |
| moderate | 4 | 1.36[0.98–1.90] | 0.07 | RE | 1.84 | 11.06 | 0.01 | 72.9 |
| low | 4 | 2.20[1.63–2.97] | 0 | FE | 5.16 | 3.27 | 0.352 | 8.3 |
| region | ||||||||
| America | 4 | 1.30[0.91–1.87] | 0.149 | RE | 1.44 | 10.85 | 0.013 | 72.4 |
| Europe | 3 | 1.07[1.00–1.14] | 0.044 | FE | 2.02 | 3.02 | 0.221 | 33.7 |
| Asia | 4 | 2.17[1.64–2.87] | 0 | FE | 5.42 | 3.33 | 0.343 | 10 |
| after removing three studies | 8 | 1.18[1.03–1.34] | 0.016 | FE | 2.41 | 10.25 | 0.175 | 31.7 |
RE: random effects; FE: fixed effects.
Figure 3Funnel plots of studies examining the association between ASD and ART using. ASDs, autism spectrum disorders.